Table 4 Cost per patient in US$, effects and incremental cost-effectiveness ratios (ICERs) of replacing current diagnostic methods by rapid diagnostic tests in two regions of Afghanistan, cost in US$ (AFN50.33 = US$1), 2009
| Â | Moderate transmission region | Low transmission region | ||||
|---|---|---|---|---|---|---|
| Â | Â | Â | Area with microscopes | Area without microscopes | ||
| Â | Microscopy arm | RDT arm | Microscopy arm | RDT arm | Clinical arm | RDT arm |
Appropriately treated patients in % (95% CI) | 76.3 (74.4; 78.2) | 83.7 (82.0; 85.3) | 76.2 (72.4; 80.0) | 80.2 (77.0; 83.7) | 12.5 (9.1; 16.1) | 65.9 (60.6; 71.1) |
Cost per patient in US$ (95% CI): | Â | Â | Â | Â | Â | Â |
 Health sector cost | 2.6 (2.6; 2.6) | 2.6 (2.5; 2.6) | 9.0 (9.0; 9.0) | 1.9 (1.8; 1.9) | 0.5 (0.5; 0.5) | 1.8 (1.8; 1.8) |
 Household cost | 7.2 (0.1; 37.6) | 6.9 (0.1; 36.0) | 11.6 (3.6; 28.4) | 11.6 (3.4; 29.5) | 10.3 (3.4; 23.6) | 11.4 (3.6; 25.7) |
 Total societal cost | 9.8 (2.7; 40.0) | 9.5 (2.6; 40.5) | 20.6 (12.5; 36.4) | 13.5 (5.2; 30.3) | 10.8 (3.9; 23.8) | 13.2 (5.7; 28.3) |
Incremental analysis (95% CI): | Replace microscopy diagnosis by RDT | Replace microscopy diagnosis by RDT | Replace presumptive diagnosis by RDT | |||
 Increase in patients appropriately treated in % | 7.4 (5.0; 9.8) | 4.0 (−0.8; 8.8) | 53.4 (47.4; 59.5) | |||
 Incremental cost in US$, health sector perspective | −0.0 (−0.0; −0.0) | −7.1 (−7.1; −7.1) | 1.3 (1.3; 1.3) | |||
 Incremental cost in US$, societal perspective | −0.3 (−4.4; 2.8) | −7.1 (−8.0; −6.0) | 2.4 (−7.5; 15.7) | |||
 ICER in US$, health sector perspective | Dominant | Dominant | 2.5 | |||
 ICER in US$, societal perspective | Dominant | Dominant | 4.5 | |||